 |
Bridging Science and Culture to Improve Drug Abuse Research in Minority Communities
This Conference was held at the Wyndham Franklin Plaza hotel in Philadelphia, P.A., September 24-26, 2001.
Biographies (continued)
| |
Philip A. Fisher, Ph.D.
Oregon Social Learning Center
160 East Fourth Avenue
Eugene, OR 97401
(541) 485-2711, ext. 117
(541) 485-7087 Fax
philf@oslc.org
Dr. Fisher is a research scientist at the Oregon Social Learning Center (OSLC) in Eugene, Oregon. He is particularly interested in prevention in the early years of life. Dr. Fisher is principal investigator (PI) on the Indian Family Wellness (IFW) Project, a 5-year study funded by NIDA that involves a collaboration with the Tribal Head Start Program in a Native American community. This project employs a multiple-baseline design to test the effectiveness of a culturally sensitive, family-based preventive intervention. The IFW Project is based on a model of community empowerment and, as such, has from the start actively involved tribal government and community members in all areasÑfrom development of the proposal to articulation of the targeted areas and techniques for the intervention, to oversight of the research process and collection and analysis of data. A major emphasis of this project is the transfer of prevention research technology into the community, thereby allowing the tribe to set its own research agenda. Dr. Fisher is also PI on the Early Intervention Foster Care (EIFC) Project, a 5-year randomized trial funded by the National Institute of Mental Health (NIMH) to test the effectiveness of a preventive intervention for maltreated preschool-aged foster children. The intervention incorporates many of the elements of OSLC's Multidimensional Treatment Foster Care program for adolescents and adds additional components such as a focus on developmental delays and a home visitation model of service delivery that are designed to meet the needs of children in this age group. The research being conducted on the EIFC Project examines how the intervention impacts multiple domains, including behavior, emotions, and neurophysiology (specifically, HPA axis activity, frontal lobe function, and memory). Related to this project, Dr. Fisher is a co-investigator of an NIMH-funded network grant examining the effects of early experiences on glucocorticoid activity in the brain. Dr. Fisher also serves on a number of national advisory groups, including a National Institute on Drug Abuse work group of Native American researchers and scholars and a National Institutes of Health study section that evaluates proposals for community-based interventions.
Jean Flagg-Newton, Ph.D.
National Center on Minority Health and Health Disparities
National Institutes of Health
Building 1, Room 260
MSC 0164
31 Center Drive
Bethesda, MD 20892-2510
(301) 402-1366
(301) 402-2517 Fax
flaggnej@od.nih.gov
Dr. Flagg-Newton is the Deputy Director of the National Center on Minority Health and Health Disparities (NCMHD). She was the Deputy Director and Coordinator for the Minority Health Initiative (MHI) with the former Office of Research on Minority Health at the National Institutes of Health (NIH) in Bethesda, Maryland. The MHI was a comprehensive program with a focus on developing and testing interventions aimed at reducing the disproportionate burden of disease among minority populations and developing successful strategies to promote healthy behaviors across the lifespan.
Dr. Flagg-Newton holds a baccalaureate degree in zoology from Tennessee State University. She earned a doctorate in physiology at Harvard University and pursued additional postdoctoral studies at the University of Miami School of Medicine, Miami, Florida. Dr. Flagg-Newton began her career as a research associate and later became an assistant professor at the University of Oklahoma Health Sciences Center. In 1988, she joined the National Institute of General Medical Sciences (NIGMS), NIH. After a brief period with the Directorate of Environmental Engineering, Tinker Air Force Base, Oklahoma, she returned to NIGMS as a Scientific Review Administrator. Dr. Flagg-Newton transferred to the Fogarty International Center, NIH, in 1995 and served as the Director of the Minority International Research Training Program. This program enables U.S. colleges and universities to support international training and research opportunities for U.S. minorities underrepresented in the scientific professions. Dr. Flagg-Newton has received numerous awards including the NIH Director's Award for leadership, initiative, and enthusiasm in promoting excellence in elementary school science education through the Science Alliance Program and the Director's Award for meritorious performance. She is a member of the American Association for the Advancement of Science.
Henry L. Francis, M.D.
Center on AIDS and Other Medical Consequences of Drug Abuse
National Institute on Drug Abuse
National Institutes of Health
Neuroscience Center, Room 5198
MSC 9593
6001 Executive Boulevard
Bethesda, MD 20892-9593
(301) 443-2104
(301) 594-6566 Fax
hf23n@nih.gov
Dr. Francis was appointed Director of the Center on AIDS and Other Medical Consequences of Drug Abuse (CAMCODA) at the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), in June 1998. The Center, with a $150 million budget, coordinates and provides leadership for NIDA's AIDS and other medical consequences research activities and collaborates with other NIH Institutes, government agencies, and nongovernment groups on issues concerning HIV/AIDS, comorbid infections, medical/mental health, and developmental consequences of drug abuse. The Center develops multidisciplinary national and international programs on HIV/AIDS, medical/mental health and developmental consequences of drug abuse, and the relationship between drug use comorbidity and diseases of public health importance. Before joining CAMCODA, he served for 2 years as Branch Chief of the Clinical Medicine Branch within the Division of Clinical and Services Research, NIDA.
Dr. Francis received his medical degree from Howard University College of Medicine in Washington, D.C., in 1978. His clinical training took place from 1978 through 1981 at the University of California's Long Beach Veterans Administration Medical Center, where he was a resident in internal medicine. He received his infectious disease training at Johns Hopkins Medical School's Division of Infectious Diseases from 1987 to 1988. Dr. Francis served as Medical Staff Fellow from 1981 to 1984 in the Laboratory of Parasitic Diseases at the National Institute of Allergy and Infectious Diseases (NIAID) at NIH.
Dr. Francis was a NIAID Expert Consultant in Tamale, Ghana, from 1981 to 1983 on an Onchocerciasis Research Project for NIAID and the Director of the Public Health Service and Belgian Project SIDA (AIDS research) Research Laboratories in Kinshasa, Democratic Republic of the Congo (Zaire), from 1984 to 1988.
Dr. Francis' positions since 1989 have included Assistant Professor of Medicine at Johns Hopkins Medical School, Special Assistant to the Director of Intramural Research, NIAID, Medical Director of Baltimore City Health Department's Early HIV Intervention Program and STD clinics, and Principal Medical Officer of the Johns Hopkins Broadway Center's Women's Comprehensive Drug Use Program.
Dr. Francis has clinical certifications from the National Board of Examiners, American Board of Internal Medicine, and American Board of Infectious Diseases. He was certified in research as an Expert in Parasitic Diseases in 1983 and Expert in Immunology in 1988 through NIAID, NIH.
Between 1986 and 1994, Dr. Francis wrote 48 HIV/AIDS articles published in the Journal of the American Medical Association, Lancet, Journal of Immunology, Journal of Infectious Diseases, Pediatrics, AIDS, New England Journal of Medicine, and Journal of Clinical Investigation.
Deborah A. Frank, M.D.
Boston Medical Center
Boston University School of Medicine
Room 2
134 Fuller Street
Brookline, MA 02446
(617) 414-5251
(617) 414-7047 Fax
dafrank@bu.edu
Dr. Frank was born in Washington, D.C., and graduated from Radcliffe College summa cum laude in 1970. She worked as a social work assistant and research assistant from 1970 to 1972. During this time, she discovered that she wanted to serve young children by becoming a pediatrician. In 1976, she graduated from Harvard Medical School and completed her residency at Children's Orthopedic Hospital in Seattle, Washington. Strongly interested in child development, she served as a Fellow at Children's Hospital Medical Center and later as the staff physician on its Failure to Thrive Team. In 1981, in response to a growing number of failure to thrive (FTT) families, she founded the Failure to Thrive Program at Boston City Hospital (now Boston Medical Center) in Boston.
Dr. Frank's Failure to Thrive Program, which is now called the Grow Clinic for Children, at Boston Medical Center, is a national model for treating FTT. The program is a comprehensive treatment plan that provides medical care, nutritional counseling, and social outreach in an effort to empower parents to help their children grow. The program also operates a food pantry and clothing room for FTT patients and their families. More than 90 percent of the children who are seen in the clinic improve and ultimately "graduate" from the program.
Over the course of her career, Dr. Frank has written numerous scientific articles and papers. Her work has focused on breastfeeding promotion, children who were exposed in utero to cocaine, nutrition among homeless pregnant women and children, failure to thrive, and the "heat or eat" phenomenon, a term she coined to describe the dilemma that many low-income families face in the winter when they must make the critical choice between heating and feeding their children. She has also reviewed for journals such as Pediatrics and Neurotoxicology and Teratology.
Cited as a respected authority in her field, Dr. Frank often gives testimony to the growing problem of hunger in the United States and its effects on children. She has served on numerous committees and advisory boards, such as the Mayor's Hunger Commission, the Massachusetts Child Hunger Initiative, and the Physicians Task Force on Childhood Hunger in Massachusetts. She has also appeared before the United States House of Representatives and the United States Senate to give testimony regarding the food assistance programs and the Low-Income Home Energy Assistance Program.
Dr. Frank was presented with the Children's Champion Award from the U.S. Committee of UNICEF in 1986, the U.S. Mayor's End Hunger Award in 1991, the Massachusetts Nutrition Board Award of Excellence in 1991, the Boston Visiting Nurse Association Home Health Care Partnership Award in 1993, the Roxbury Comprehensive Community Health Center We Take Your Health to Heart Award in 1995, and Rosie's Place Share Your Heart Award in 2000.
Crystal M. Fuller, Ph.D.
Department of Epidemiology
Mailman School of Public Health
Columbia University
PH 18-120
622 West 168th Street
(212) 305-6223
(212) 305-9413 Fax
cf317@columbia.edu
Dr. Fuller is an Assistant Professor at Mailman School of Public Health, Columbia University, and an infectious disease epidemiologist with the Center for Urban Epidemiologic Studies, New York Academy of Medicine. Her research involves high-risk behavior and social-contextual effects contributing to injection drug use and disease transmission among young drug users.
Kenneth W. Griffin, Ph.D., M.P.H.
Institute for Prevention Research
Department of Public Health
Weill Medical College of Cornell University
411 East 69th Street
New York, NY 10021
(212) 746-1270
(212) 746-8390 Fax
kgriffin@med.cornell.edu
Dr. Griffin is an Assistant Professor in the Department of Public Health at Weill Medical College of Cornell University and also serves as Senior Data Analyst at Cornell's Institute for Prevention Research. In his latter capacity, Dr. Griffin evaluates the effectiveness of the Institute's intervention programs using a variety of statistical methodologies. In addition, Dr. Griffin conducts epidemiological and etiological studies of adolescent risk behaviors, including tobacco, alcohol, and marijuana use; illicit drug use; and violent and aggressive behaviors. His research examines how demographic factors, social influence variables, and individual characteristics are associated with the initiation and escalation of substance use and aggression among youth from a variety of backgrounds.
Before joining Cornell, Dr. Griffin spent 2 years as a postdoctoral fellow at Columbia University in the Department of Psychiatry and the HIV Center for Clinical and Behavioral Studies. Dr. Griffin holds an M.P.H. degree in epidemiology from Columbia (1997), a doctorate in social and health psychology from the State University of New York at Stony Brook (1995), and a B.A. degree in psychology from the University of Chicago (1986).
Ken Harewood, Ph.D.
North Carolina Central University
Room 104
1801 Fayetteville Street
Durham, NC 27707
(919) 530-7025
(919) 530-7998 Fax
kharewood@wpo.nccu.edu
Dr. Harewood received his bachelor's degree from New York University and his doctorate from City University of New York. He worked for 23 years in the cancer research department of Pfizer Inc. In 1994, he joined the faculty at Florida A&M University and later moved to North Carolina Central University, where he serves as Director of the new Biomedical/Biotechnology Research Institute.
Murelle G. Harrison, Ph.D.
Department of Psychology
Southern University
Baton Rouge, LA 70813
(225) 771-2990
(225) 771-2082 Fax
mgharripsy@aol.com
Dr. Harrison is the principal investigator of a $2.2 million, 5-year grant from the National Institute on Drug Abuse to prevent substance use among rural African American youths. She is an Associate Professor of Psychology at Southern University in Baton Rouge, Louisiana.
Carl L. Hart, Ph.D.
Department of Psychiatry
College of Physicians and Surgeons
Columbia University
Unit 120
1051 Riverside Drive
New York, NY 10027
(212) 543-5884
(212) 543-5991
clh42@columbia.edu
Dr. Hart is an Assistant Professor of Clinical Neuroscience at Columbia University's College of Physicians and Surgeons and is a Research Scientist at the New York State Psychiatric Institute in the Division on Substance Abuse. He is currently conducting laboratory research with human participants, focusing on using the laboratory as an interface between non-human research and the clinic.
Nicholas S. Ialongo, Ph.D.
Department of Mental Hygiene
Bloomberg School of Public Health
Johns Hopkins University
3400 North Charles Street
Baltimore, MD 21218
(410) 550-3441
(410) 550-3461 Fax
nialongo@jhsph.edu
Dr. Ialongo is Associate Professor in the Department of Mental Hygiene of the Johns Hopkins University Bloomberg School of Public Health. He is a child and family clinical psychologist and received his doctoral degree in psychology from Michigan State University in 1987. Dr. Ialongo is principal investigator on a grant funded by the National Institute on Drug Abuse and the National Institutes of Mental Health to follow up two universal preventive interventions designed to prevent mental health and substance abuse disorders.
Martin Y. Iguchi, Ph.D.
Drug Policy Research Center
RAND
1700 Main Street
Santa Monica, CA 90407-2138
(310) 402-1984
(310) 451-7004 Fax
iguchi@rand.org
Dr. Iguchi is a Senior Behavioral Scientist and Director of the Drug Policy Research Center at RAND in Santa Monica, California. Dr. Iguchi received his A.B. degree in liberal arts from Vassar College and his M.A. and Ph.D. degrees in experimental psychology from Boston University. He completed 2 years of postdoctoral training in drug abuse and behavioral pharmacology at the Johns Hopkins University School of Medicine.
Dr. Iguchi is a member of the Center for Substance Abuse Treatment's National Advisory Council, a member of the Board of Directors of the College on Problems of Drug Dependence, a member of the Editorial Board for Drug and Alcohol Dependence, and a principal investigator on several National Institute on Drug Abuse treatment grants.
|
|
[More Biographies][Conference Agenda][Conference Index]
|
|
